D
Pacira BioSciences, Inc. PCRX
$21.77 $0.321.49% NASDAQ
Recommendation
Dividend Power Score
Prev Close
$21.45
Volume
766,675
Avg Vol (90D)
799,554
Market Cap
$922.81M
Dividend & Yield
--
52-Week Range
$18.80 - $27.64
P/E (TTM)
48.61
EPS (TTM)
$0.44
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
2/12/2026 - Globe Newswire
Is Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Stock Price Struggling As A Result Of Its Mixed Financials?
2/12/2026 - Simply Wall St
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
2/12/2026 - Globe Newswire
Pacira BioSciences, Inc. $PCRX Holdings Raised by Impax Asset Management Group plc
2/12/2026 - MarketBeat
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/9/2026 - Globe Newswire
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away
2/9/2026 - Seeking Alpha - Long Ideas
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away
2/9/2026 - SeekingAlpha
Pacira BioSciences (PCRX, $20.35) entered Downtrend as Momentum indicator drops below 0 level on Feb 05, 2026
2/6/2026 - Tickeron - Technical Analysis
Pacira BioSciences (NASDAQ:PCRX) SVP Sells $83,240.00 in Stock
2/4/2026 - MarketBeat
Pacira BioSciences (NASDAQ:PCRX) SVP Lauren Riker Sells 4,000 Shares
2/4/2026 - MarketBeat
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
2/3/2026 - Zacks Investment Research
Pacira BioSciences (PCRX, $21.22) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 2, 2026
2/3/2026 - Tickeron - Stocks
Great Lakes Advisors LLC Decreases Stake in Pacira BioSciences, Inc. $PCRX
2/1/2026 - MarketBeat
Gagnon Securities LLC Grows Stock Holdings in Pacira BioSciences, Inc. $PCRX
1/30/2026 - MarketBeat
Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Recommendation of "Hold" by Analysts
1/29/2026 - MarketBeat
Bristol Myers Squibb (BMY) Exec Joins Pacira BioSciences Board
1/28/2026 - GuruFocus
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
1/28/2026 - GuruFocus
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
1/28/2026 - Globe Newswire
Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why
1/27/2026 - Zacks Investment Research
Will Pacira (PCRX) Beat Estimates Again in Its Next Earnings Report?
1/27/2026 - Zacks Investment Research
Pacira BioSciences (PCRX, $20.24) RSI Indicator left the oversold zone on January 21, 2026
1/22/2026 - Tickeron - Stocks
IHE's Underlying Holdings Imply 11% Gain Potential
1/21/2026 - ETF Channel
HARBOR CAPITAL ADVISORS, INC. Sells 3 Shares of Pacira BioSciences Inc (PCRX)
1/20/2026 - GuruFocus
TOTH FINANCIAL ADVISORY CORP Sells 12,000 Shares of Pacira BioSciences Inc (PCRX)
1/20/2026 - GuruFocus
Revenues Working Against Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Share Price Following 28% Dive
1/17/2026 - Simply Wall St
Income Statement
Total Revenue (TTM)
$716.79M
EBITDA (TTM)
$145.07M
EBIT (TTM)
$59.65M
Net Income (TTM)
$21.44M
Balance Sheet
Total Assets (Q)
$1.30B
Total Debt (Q)
$425.31M
Total Liabilities (Q)
$570.36M
Book Value Per Share (Q)
$16.93
Cash Flow
Cash from Operations (TTM)
$141.44M
Cash from Investing (TTM)
$79.78M
Cash from Financing (TTM)
-$319.93M
Net Change in Cash (TTM)
-$98.38M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
0.02
7-Day Total Return
5.27%
30-Day Total Return
-15.88%
60-Day Total Return
-8.84%
90-Day Total Return
-8.80%
Year to Date Total Return
-11.00%
1-Year Total Return
-17.94%
2-Year Total Return
-25.47%
3-Year Total Return
-46.58%
5-Year Total Return
-70.70%
52-week Low
Jan 20, 2026 - $18.80
52-week High
Apr 08, 2025 - $27.64
Valuation
Market Cap
$922.81M - Small Cap
Enterprise Value
$1.10B
Price/Sales (TTM)
1.33
Price/Book (Q)
1.27
Dividends and Shares
Shares Outstanding
44.46M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pacira.com
Phone Number
650-242-8052
Address
2000 Sierra Point Parkway
Brisbane, CA 94005
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in... more
NASDAQ 02/13/2026 4:00PM Eastern Quotes delayed